2019
LVAD Survival May Be Predicted by Preoperative Lymphopenia
Stawiarski K, Agboola O, Jacoby D, Bellumkonda L, Sugeng L, Ahmad T, Chen M, McCloskey G, Geirsson A, Anwar M, Bonde P. LVAD Survival May Be Predicted by Preoperative Lymphopenia. The Journal Of Heart And Lung Transplantation 2019, 38: s63-s64. DOI: 10.1016/j.healun.2019.01.142.Peer-Reviewed Original ResearchAbsolute lymphocyte countCause mortalityLVAD patientsImmune modulator therapyImpact of lymphopeniaImportant prognostic indicatorCells/μL.Kaplan-Meir plotsLog-rank statisticsPhysiologic stress responseLVAD survivalPreoperative lymphopeniaSplanchnic congestionCox modellingLymphocyte countLymphocyte levelsLymphopenic patientsUnadjusted survivalWorse survivalHeart failurePrognostic roleSerum sodiumSingle centerPatient groupLVAD therapy
2018
Role of Class I and Class II Panel Reactive Antibodies in Predicting Post-Heart Transplant Rejection and Survival in the Current Era.
Kunnirickal S, Bellumkonda L. Role of Class I and Class II Panel Reactive Antibodies in Predicting Post-Heart Transplant Rejection and Survival in the Current Era. Journal Of Cardiac Failure 2018, 24: s112. DOI: 10.1016/j.cardfail.2018.07.414.Peer-Reviewed Original ResearchPanel reactive antibodyClass II antibodiesClass II panel reactive antibodiesClass I antibodiesYear of transplantationII antibodiesLong-term survivalClass IRecipient ageReactive antibodiesI antibodiesElevated panel reactive antibodyOverall long-term survivalLonger waitlist timesPrior heart transplantationLong-term mortalityMethods Retrospective analysisSame prognostic implicationsClass 2 antibodiesHeart transplantationHLA mismatchesHazard ratioIschemic timeHeart transplantPrognostic role